Brimonidine and pupillary diameter.
L
L
Mastropasqua
P
P
Carpineto
M
M
Ciancaglini
D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage* / Q000009:adverse effects; D000068438:Brimonidine Tartrate; D004305:Dose-Response Relationship, Drug; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D009798:Ocular Hypertension / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D011680:Pupil / Q000187:drug effects*; D011810:Quinoxalines / Q000008:administration & dosage* / Q000009:adverse effects; D012449:Safety
D000316:Adrenergic alpha-Agonists; D009883:Ophthalmic Solutions; D011810:Quinoxalines; D000068438:Brimonidine Tartrate